About this trial
To assess whether changes in electrical impedance - measured using an electrical impedance tomography (EIT) chest belt - can be used to derive changes in pulmonary artery pressure (PAP) in critically ill patients when compared to invasive gold-standard PAP measured using pulmonary artery catheter (PAC).
Eligibility criteria
Qualifiers
Age ≥ 18-year-old.
Intubated patients in the ICU with clinical decision to monitor PAP and cardiac output using a PAC.
Disqualifiers
Patients with implanted or external thoracic electronic devices (e.g., pacemaker) or thoracic metal implants.
Known pregnancy or lactating patients.
Open lung injuries or pneumothorax.
Open wounds, drainages, burns or rashes of the upper thorax.
Trial design
Treatments tested in this trial
- Electrical impedance tomography
Treatment groups
Sponsors and collaborators
Insel Gruppe AG, University Hospital Bern
Lead sponsor
CSEM Centre Suisse d'Electronique et de Microtechnique SA - Recherche et Developpement
Collaborator